Blake Borgeson
Director at Recursion Pharmaceuticals, Inc. (RXRX)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $4.3M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Oct 7SEC | RXRXRecursion Pharmaceuticals, Inc. | Sell Plan | 50,0006,108,287 held (−1%) | $4.84 | $242K | -9.9% |
| Sep 2SEC | RXRXRecursion Pharmaceuticals, Inc. | Sell Plan | 30,0006,158,287 held (−0%) | $3.34 | $100K | +30.5% |
| Aug 6SEC | RXRXRecursion Pharmaceuticals, Inc. | Sell Plan | 30,0006,188,287 held (−0%) | $3.25 | $98K | +34.2% |
| Jul 9SEC | RXRXRecursion Pharmaceuticals, Inc. | Sell Plan | 40,0006,218,287 held (−1%) | $3.96 | $158K | +10.1% |
| Jun 4SEC | RXRXRecursion Pharmaceuticals, Inc. | Sell Plan | 30,0006,169,863 held (−0%) | $3.68 | $110K | +18.5% |
| May 7SEC | RXRXRecursion Pharmaceuticals, Inc. | Sell Plan | 30,0006,199,863 held (−0%) | $3.52 | $106K | +23.9% |
| Apr 8SEC | RXRXRecursion Pharmaceuticals, Inc. | Sell Plan | 30,0006,229,863 held (−0%) | $3.10 | $93K | +40.6% |
| Mar 4SEC | RXRXRecursion Pharmaceuticals, Inc. | Sell Plan | 170,0006,259,863 held (−3%) | $3.46 | $588K | +26.0% |
| Feb 6SEC | RXRXRecursion Pharmaceuticals, Inc. | Sell Plan | 220,0006,429,863 held (−3%) | $4.20 | $924K | +3.8% |
| Jan 8SEC | RXRXRecursion Pharmaceuticals, Inc. | Sell Plan | 220,0006,649,863 held (−3%) | $4.36 | $959K | +0.0% |
| Dec 4SEC | RXRXRecursion Pharmaceuticals, Inc. | Sell Plan | 220,0006,869,863 held (−3%) | $4.37 | $961K | -0.2% |
- Sell
Director Blake Borgeson sold $242K of RXRX at $4.84 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Blake Borgeson sold $100K of RXRX at $3.34 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Blake Borgeson sold $98K of RXRX at $3.25 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Blake Borgeson sold $158K of RXRX at $3.96 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Blake Borgeson sold $110K of RXRX at $3.68 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Blake Borgeson sold $106K of RXRX at $3.52 — pre-scheduled 10b5-1 plan sale.